Bloomberg Intelligence cover image

Dow Chemical, Fed Decision, Oprah

Bloomberg Intelligence

CHAPTER

Oprah's Impact on Weight Loss Drugs

The chapter delves into Oprah's involvement with promoting GLP-1 drugs for weight loss, despite not disclosing the specific one she uses. It discusses her association with these medications and the evolving dynamics of the weight loss industry, including the intersection with plastic surgery trends. The segment also highlights the challenges faced by pharmaceutical companies in meeting the rising demand for weight loss drugs and the potential risks to Oprah's reputation.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner